Epidemiological studies correlate increased serum IGF-I levels and insulin-like growth factor binding proteins with increased risk of breast cancer [15,16], and increased levels of IGFIR have been found in human breast cancer specimens, although the gene is rarely amplified [17-19]. Here, IGF1 is linked to breast carcinoma.